Track topics on Twitter Track topics that are important to you
LOS ANGELES, CA -- (Marketwired) -- 08/03/16 -- miVIP Surgery Centers, the nationally recognized leader in minimally invasive outpatient surgical procedures, is pleased to announce its recent acquisition of the da Vinci® Xi Surgical System.
Designed to advance the level of technology used in minimally invasive surgical procedures, the da Vinci® Xi Surgical System can be used across a broad range of multi-quadrant procedures in the areas of gynecology, urology, thoracic and cardiac surgery.
The da Vinci® Xi Surgical System enables efficient access throughout the abdomen or chest, expanding upon core da Vinci® System features, including wristed instruments, 3D-HD visualization, intuitive motion, and an ergonomic design.
As with every da Vinci® Xi Surgical System, the surgeon is in total control of the robotic assisted system, which translates hand movements into smaller, more precise movements of tiny instruments inside the patient's body.
In addition, the da Vinci® Xi Surgical System's immersive 3D-HD vision system provides each doctor with a highly magnified view, virtually extending their eyes and hands into the patient.
Key features of the advanced da Vinci® Xi Surgical System include:
The acquisition of the da Vinci® Xi Surgical System helps underscore the commitment of miVIP Surgery Centers to providing patients with the latest state-of-the-art technology, ensuring an optimal surgical environment.
miVIP is the nationally recognized leader in minimally invasive outpatient procedures and an industry pioneer in robot-assisted procedures with over 1,500 surgeries performed across multiple specialties.
The world-class surgical experts at miVIP are leaders in the field of robotic surgery and are supported by a dedicated medical staff that is committed to ensuring that every patient receives support through every step of their journey.
For more information about miVIP Surgery Centers, please visit www.mivipnow.com.
For clinical data on the da Vinci® Surgical System, click here. For more information on the da Vinci® Surgical System, click here. For more information from miVIP on the da Vinci® Xi Surgical System, click here.
Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques. If your doctor needs to convert the surgery to another surgical technique, this could result in a longer operative time, additional time under anesthesia, additional or larger incisions and/or increased complications. Individual surgical results may vary. Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci® Surgery. Patients should talk to their doctor to decide if da Vinci® is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. Please also refer to www.daVinciSurgery.com/Safety for Important Safety Information. Product names are trademarks or registered trademarks of their respective holders. PN 1007644 Rev A 5/14
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3040705Gio Rodriguez miVIP Surgery Centers (855) 696.4847 NEXT ARTICLE
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...